Back to Isotope Catalog
R-11059

Dapoxetine hydrochloride (d7)

Stable isotope standard for analytical research and method development.

Module Type
Stable Isotope Standards
Category
Drugs & TDM
CAS
1132642-56-8
Unlabeled CAS
129938-20-1
PubChem CID
154828600
Molecular Formula
C21H17D7ClNO
Molecular Weight
348.9
AI Isotope Property & Application AnalysisShow

Isotope Summary

Labels
D7
Labeled atoms
7
Isotope positions
Partially confirmed in structure
Calculation reliability
Medium, some information should be confirmed

Mass & MS Parameters

Unlabeled exact mass
341.154642 Da
Labeled exact mass
348.198579 Da
Exact mass shift
7.043937 Da
Nominal mass shift
7
Ionm/zStatus
[M+H]+349.205856Theoretical
[M+Na]+371.187797Theoretical
[M+NH4]+366.232402Theoretical
[M-H]-347.191303Theoretical

Label Stability

Overall
Low risk
Calculation reliability
Medium, some information should be confirmed
  • Carbon-bound deuterium is evaluated by local chemical environment; isotope effects should still be checked experimentally.

Internal Standard Suitability

Rating
High
Chromatographic similarity
Possible isotope effect
Natural isotope overlap
Low
  • Exact mass separation is 7.043937 Da; MS channel separation should be verified in the final method.
  • The unlabeled parent mass was derived from the isotope structure because a curated parent structure was not matched.
  • Overall suitability: High.

Recommended Applications

LC-MS/MS Quantitative Internal Standard
Recommended

LC-MS/MS Quantitative Internal Standard is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

Isotope Dilution Mass Spectrometry
Recommended

Isotope Dilution Mass Spectrometry is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

GC-MS Internal Standard
Possible

GC-MS Internal Standard is classified as Possible based on isotope mapping, mass separation, and label-stability rules.

Clinical Mass Spectrometry
Possible

Clinical Mass Spectrometry is classified as Possible based on isotope mapping, mass separation, and label-stability rules.

Bioanalytical Method Development
Recommended

Bioanalytical Method Development is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

AI Interpretation

This analysis is based on isotope-aware structure data. The compound contains D7, with an exact mass shift of 7.043937 Da. Label stability is assessed as Low risk, and internal-standard suitability is High. These results support analytical method development and require experimental validation.

AI-assisted analytical guidance is intended for method-development support. Actual isotope stability, chromatographic behavior, fragmentation and MRM transitions should be experimentally validated.